Literature DB >> 7612910

Ha-ras rare alleles in breast cancer susceptibility.

K Conway1, S Edmiston, D B Fried, B S Hulka, P A Garrett, E T Liu.   

Abstract

Over the last several years, evidence has accumulated to support the idea that rare Ha-ras polymorphisms are associated with inherited susceptibility to certain human cancers. A recent epidemiologic study conducted at our institution found a significant association specifically with breast cancer, although the mechanism underlying this relationship remains unclear. We have proposed that rare Ha-ras alleles are markers of a genomic instability that predisposes to breast cancer. To address this hypothesis, we are investigating the relationship between the presence of rare alleles and another form of instability, gene amplification, and are developing new methodologies both to improve VNTR allele length detection and to characterize the internal repeat sequence variations of the various alleles. These studies should enable us to more clearly define the role of this region in cancer development by delineating VNTR structure and function and the mechanisms of rare allele generation. Ultimately, we hope to identify VNTR characteristics that will permit more accurate cancer risk assessment.

Entities:  

Mesh:

Year:  1995        PMID: 7612910     DOI: 10.1007/BF00694750

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  47 in total

1.  Rare Ha-ras and c-mos alleles in patients with intracranial tumors.

Authors:  U Diedrich; O Eckermann; J Schmidtke
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

2.  Allelic diversity at minisatellite MS205 (D16S309): evidence for polarized variability.

Authors:  J A Armour; P C Harris; A J Jeffreys
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

3.  Complex gene conversion events in germline mutation at human minisatellites.

Authors:  A J Jeffreys; K Tamaki; A MacLeod; D G Monckton; D L Neil; J A Armour
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

4.  Increased erbB-2 gene copies and expression in multiple stages of breast cancer.

Authors:  J D Iglehart; M H Kraus; B C Langton; G Huper; B J Kerns; J R Marks
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

5.  Comparison between the allelic frequency distribution of the Ha-ras 1 locus in normal individuals and patients with lymphoma, breast, and ovarian cancer.

Authors:  B Corell; B Zoll
Journal:  Hum Genet       Date:  1988-07       Impact factor: 4.132

6.  Polymorphism of the c-Ha-ras-1 proto-oncogene in sporadic and familial breast cancer.

Authors:  R B Barkardóttir; O T Jóhannsson; A Arason; V Gudnason; V Egilsson
Journal:  Int J Cancer       Date:  1989-08-15       Impact factor: 7.396

7.  In vivo amplification and rearrangement of c-myc oncogene in human breast tumors.

Authors:  M Bonilla; M Ramirez; J Lopez-Cueto; P Gariglio
Journal:  J Natl Cancer Inst       Date:  1988-07-06       Impact factor: 13.506

8.  Allelic variation of reporter gene activation by the HRAS1 minisatellite.

Authors:  M Green; T G Krontiris
Journal:  Genomics       Date:  1993-08       Impact factor: 5.736

9.  HRAS protooncogene polymorphism and breast cancer.

Authors:  P A Garrett; B S Hulka; Y L Kim; R A Farber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1993 Mar-Apr       Impact factor: 4.254

10.  Ha-ras restriction fragment length polymorphisms in colorectal cancer.

Authors:  F S Wyllie; V Wynford-Thomas; N R Lemoine; G T Williams; E D Williams; D Wynford-Thomas
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.